CompaniesMahzi Therapeutics
Mahzi Therapeutics logo

Mahzi Therapeutics

active
San Mateo, CA, United States
Founded 2020
Website
About

Gene therapy for rare genetic neurodevelopmental disorders

Areas of Focus

Categories

Gene Therapy, RNA & Peptide TherapyBiotech
Team (27)
AaronOlsen
AaronOlsen
Chief Financial Officer
Mahzi Therapeutics
executive
AdaSan Diego
Senior Director, Clinical Operations
Mahzi Therapeutics
team_member
AllysonBerent, DVM, DACVIM
Chief Development Officer
Mahzi Therapeutics
team_member
ArrowMark Partners
Mahzi Therapeutics
team_member
CamilleSamuels
CamilleSamuels
Venrock
Mahzi Therapeutics
team_member
CariZavattero
CariZavattero
Executive Coordinator
Mahzi Therapeutics
team_member
View all 27 team members →
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

12

By Phase

PHASE1/PHASE2: 1

By Status

NOT_YET_RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2025
2026
2027
2028
2029
2030
Today
NCT07135050
Hover over trial bars to see details

Recent Trials

NCT07135050Lead Sponsor
Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome
PHASE1/PHASE2Not yet recruiting
12 participants
Started: Jan 31, 2026 · Completed: Jul 31, 2029
Funding History (3)
D/A
Jul 8, 2024
Filing
D/A
Nov 14, 2022
Filing
D
Oct 21, 2021
Filing
Locations (1)
Headquarters
San Mateo, CA, United States
Map

Loading map...